Ajay Goel, PhD
City of Hope Medical Center
Emerging Leaders
not ranked
Current Leaders
#20122 pts
All-Time Leaders
#4154 pts
Scored by the scientific impact (publications, citations, press) of the trials they lead, weighted by role. First trial 2020. 15 trials as lead/chair. How it works →
Trials led — by scientific impact
A Liquid Biopsy Assay For The Non-Invasive Early Detection of Advanced Adenomas and Colorectal Cancer
N/ARecruitingCity of Hope Medical Center
10
impact
Early Detection of Pancreatic Cancer: Prospective Study
N/ARecruitingCity of Hope Medical Center
10
impact
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
N/ARecruitingCity of Hope Medical Center
10
impact
Predicting Recurrence After Curative-Intent Resection of T1 Colorectal Cancer With Transcriptomics
N/ACompletedCity of Hope Medical Center
8
impact
Early Detection of Stomach Cancer With a Liquid Biopsy Based on Exosomal Micro-RNA
N/ACompletedCity of Hope Medical Center
8
impact
An Exosome-based Liquid Biopsy Signature for Pre-operative Identification of Lymph Node Metastasis in Patients With Intrahepatic Cholangiocarcinoma
N/ACompletedCity of Hope Medical Center
7
impact
An Exosome-based Liquid Biopsy Signature for Preoperative Identification of Occult Liver Metastasis in Patients With Pancreatic Ductal Adenocarcinoma
N/ACompletedCity of Hope Medical Center
7
impact
Predicting Recurrence-Free Survival in Stage III and High-Risk Stage II Colorectal Cancer After Curative-Intent Treatment
N/ARecruitingCity of Hope Medical Center
7
impact
Development of a cfDNA 5mC/5hmC-based Epigenetic Biomarker Panel to Predict Chemotherapy Efficacy in Metastatic Colorectal Cancer
N/ARecruitingCity of Hope Medical Center
7
impact
Machine Learning-Based Exosomal microRNA Signature for Preoperative Staging and Chemotherapy Eligibility in Colon Cancer
N/ARecruitingCity of Hope Medical Center
7
impact
Development of a cfDNA 5mC/5hmC-based Epigenetic Biomarker Panel to Identify Determinants of Response In VEGF/EGFR-targeted Therapy for Metastatic Colorectal Cancer
N/ARecruitingCity of Hope Medical Center
7
impact
Predicting Long-Term Recurrence-Free and Overall Survival in Early-Onset Colorectal Cancer Survivors
N/ACompletedCity of Hope Medical Center
7
impact
Machine Learning-based Exosome Liquid Biopsy Enables Stratification of Occult Metastasis Risk in Patients With Intrahepatic Cholangiocarcinoma
N/ACompletedCity of Hope Medical Center
6
impact
Liquid Biopsy Using Exosomal miRNA for Intrahepatic Cholangiocarcinoma Detection
N/ACompletedCity of Hope Medical Center
6
impact
An Exosome-Based Liquid Biopsy Assay to Detect Molecular Residual Disease for the Identification of High-Risk Patients With Stage II-III Colorectal Cancer
N/ACompletedCity of Hope Medical Center
6
impact
Splicing-Based Predictive Learning for Individual Chemotherapy Evaluation in Colorectal Cancer (SPLICE)
N/ARecruitingCity of Hope Medical Center
6
impact
SYNERGY Study: Early Detection Through Integrated Evaluation of Cell-Free and Exosomal microRNAs for Biomarker-Guided Screening of Esophageal Squamous Cell Carcinoma
N/ARecruitingCity of Hope Medical Center
6
impact
Development and Validation fo an Exosome-Based and Machine Learning Powered Liquid Biopsy for the Detection of Early-Onset Colorectal Cancer
N/ARecruitingCity of Hope Medical Center
6
impact
Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA
N/ARecruitingCity of Hope Medical Center
6
impact
An Exosomal miRNA Based Predictive Model for Personalized Neoadjuvant Chemotherapy Selection in Pancreatic Ductal Adenocarcinoma
N/ARecruitingCity of Hope Medical Center
5
impact
Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases
N/ARecruitingCity of Hope Medical Center
5
impact
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
N/ARecruitingCity of Hope Medical Center
2
impact
A Model of Epigenetic Biomarkers Based on cfDNA 5mC/5hmC for Early Detection of Colorectal Cancer
N/AActiveCity of Hope Medical Center
2
impact
A Liquid Biopsy to Screen for Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma: the EMERALD Multi-center Study.
N/ACompletedCity of Hope Medical Center
2
impact